4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001522780-26-000007
Director sold 12,567 shares at an average $32.03 ($402,528)
- Director acquired 26,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kaye Edward M. MD · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-14 | Exercise or conversion : show line 1 in the form | +26,250 | 137,124 | D | ||
| 2026-08-18 | Sale : show line 2 in the form | −11,930 | $32.01 | $381,846 | 125,194 | D |
| 2026-08-18 | Sale : show line 3 in the form | −637 | $32.47 | $20,682 | 124,557 | D |
| Open-market sales · 12,567 sh · avg $32.03 · $402,528 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-14 | Exercise or conversion : show line 4 in the form Performance Stock Units | −26,250 | 0 | D |
Loading xslF345X06/form4-08192026_120851.xml…